Sort
15,842 grants matching “pancreatic cancer”
Early Detection of Pancreatic Cancer with Targeted Contrast-enhanced Ultrasound
$211,699Juergen Karl Willmann · Stanford University · R21 · FY2009 · CA
Experimentally Validated Mathematical Modeling of Oncolytic Virus Infection
$211,621Wolfgang Michael Korn · University Of California, San Francisco · R01 · FY2007 · CA
Therapeutic Application of Novel Stat3 Inhibitors in Breast and Pancreatic Cancer
$211,529James K Turkson · University Of Central Florida · R01 · FY2010 · CA
Targeting cancer cachexia drivers using antibody-based approaches
$211,518Azeddine Atfi · Wayne State University · R01 · FY2025 · CA
T-32 NIH Postdoctoral Training Program in Nanotechnology for Cancer Medicine NTCM
$211,453Denis Wirtz · Johns Hopkins University · T32 · FY2011 · CA
Profiling Pancreatic Cancer Metabolism and Tumor Microenvironment for Therapy
$211,410Anne Le · Johns Hopkins University · R21 · FY2013 · CA
AGX1/2 inhibitors as key modulators of the hexosamine biosynthetic pathway
$211,410Kevin J Yarema · Johns Hopkins University · R21 · FY2015 · CA
Anti-PV1 Therapy for Pancreatic Cancer
$211,410Radu Virgil Stan · Dartmouth College · R21 · FY2013 · CA
Targeting RAS signaling with CDK and AKT inhibition in pancreatic cancer
$211,410Nilofer S. Azad · Johns Hopkins University · R21 · FY2013 · CA
Identifying Familial Pancreatic Cancer Predisposition Genes
$211,410James R. Eshleman · Johns Hopkins University · R21 · FY2012 · CA
Omega-6 Fat Promotion of Mutant Kras-Induced Pancreatic Neoplasia
$211,400Paul Joseph Grippo · Northwestern University At Chicago · R21 · FY2008 · CA
HMG-CoA reductase inhibitor, tea polyphenols and pancreatic cancer prevention
$211,400Guang-Yu Yang · Northwestern University At Chicago · R21 · FY2008 · CA
Elucidating the molecular and cellular mechanisms of immune evasion in pancreatic cancer
$211,308William A Freed-Pastor · Dana-Farber Cancer Inst · K08 · FY2023 · CA
Elucidating the molecular and cellular mechanisms of immune evasion in pancreatic cancer
$211,308William A Freed-Pastor · Dana-Farber Cancer Inst · K08 · FY2022 · CA
Elucidating the molecular and cellular mechanisms of immune evasion in pancreatic cancer
$211,308William A Freed-Pastor · Dana-Farber Cancer Inst · K08 · FY2024 · CA
Characterization of Cancer Transcriptomes using Next Generation Sequencing
$211,158Christopher A Maher · Washington University · R00 · FY2013 · CA
Plasmalemma vesicle-associated protein (PV-1) as a novel target in cancer immunot
$211,084Radu Virgil Stan · Dartmouth College · R21 · FY2013 · CA
Characterization of lcmt in Animal Models of Cancer
$211,028Mark Reid Philips · New York University School Of Medicine · R01 · FY2014 · CA
Core B â Human Biospecimen and Advanced Sequencing Core
$210,973Leonidas G Koniaris · Medical University Of South Carolina · P01 · FY2024 · CA
Education and Outreach Unit
$210,857Haifa Shen · Methodist Hospital Research Institute · U54 · FY2020 · CA
Taste Receptor Family 2 Member 9 as a novel target for imaging Cancer Associated Fibroblasts in pancreatic cancer
$210,703Kimberly A. Kelly · University Of Virginia · R21 · FY2018 · CA
Developing a patient derived model platform to treat BRCA1/2-mutant pancreatic cancers
$210,688Jonathan Brody · Oregon Health & Science University · R21 · FY2022 · CA
Novel Strategies to Broaden the Impact of HIFU Therapy in Cancer Management
$210,600Pei Zhong · Duke University · R21 · FY2008 · CA
Development of a CES 2-Activated Doxazolidine Prodrug for Pancreatic Cancer
$210,589Tad H Koch · University Of Colorado · R21 · FY2009 · CA
Neoadjuvant Stroma Modification in Pancreatic Cancer
$210,508Igor Astsaturov · Research Inst Of Fox Chase Can Ctr · R21 · FY2021 · CA